Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
229.00    0.00 (0.00%)
Bid:
228.50
Ask:
229.50
Spread: 1.00 (0.438%)
Market Cap: £632.99m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

17 Nov 2010 07:00

RNS Number : 3048W
Morgan Crucible Co PLC
17 November 2010
Β 

ο»Ώ

Press Release

Interim Management Statement

The Morgan Crucible Company plc

17th November 2010

Β 

Β 

The statement below constitutes Morgan Crucible's Interim Management Statement for the period from 4th July to 17th November 2010.

Β 

Β 

Β·; The Group has continued to see positive trading momentum over the period since it reported its half year results

Β 

Β·; Profits for the full year are now expected to be in the top half of analyst forecasts*

Β 

Β·; In the ten month period to October year-on-year revenue growth was c.7%. Excluding NP Aerospace and at constant currency, revenue growth over the same period was c.16%, compared to the c.10% reported at the half year

Β 

Β·; Good progress is being made to realise the benefits of the divisional streamlining that was announced at the interim results. Our expectation remains to deliver at least Β£5m of cost savings in 2011 rising to Β£6-8m in 2012

Β 

Β·; The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end, driven by good cash generation from the positive trading performance

Β 

Β 

* Analyst forecasts for 2010 EBITA (before restructuring) are between Β£98.8m and Β£109.0m.

Β 

Β 

Β 

Outlook

Β 

With the Group continuing to see good trading momentum across most of its end markets, our outlook remains positive. In addition our ongoing focus on higher margin niche end markets, coupled with continuing benefits from cost base reductions, leaves us well placed for further progress into 2011.

Β 

Β Β 

Morgan Ceramics Division

Β 

The Technical Ceramics and Thermal Ceramics businesses were merged in July 2010 and are now run under a single integrated leadership team which is making good progress to realise both cost synergies and revenue growth opportunities.

Β 

Technical Ceramics Business

Β 

The majority of markets that Technical Ceramics serve have been showing improved demand during the year. US markets, in particular, have recovered strongly, Asian demand is growing well and Europe, though more subdued, is also showing a positive trend. Across the Technical Ceramics business, strong order intake through the year has resulted in order books building steadily from the trough levels of 2009.

Β 

Aerospace markets have recovered well from the slowdown seen in mid 2009 with our US metals business, in particular, benefitting from its alignment with this sector.

Demand for consumer electronics has been robust and the take-up of our new products in hard disk drive applications is very encouraging. The medical device market remains soft for the time being, mainly due to destocking in the supply chain, but there are some signs of recovery potential for 2011. In power generation, the continued weakness of the industrial gas turbine market held back our Certech businesses, in both the US and Europe, whilst solar, which started the year slowly, picked up in the second half.

Β 

Β 

Thermal Ceramics Business

Β 

Thermal Ceramics continued to see improving end market demand across all regions in the third quarter of the year. As a result, order books in emerging markets, particularly China and India, have continued to improve and the North America and Europe regions have also seen an increase in activity.

Β 

The chemical and petroleum sector remains robust with good demand in the Middle East and Latin America. Iron and steel demand has recovered from a very low base, as well as revenues from the automotive industry.

Β 

Β 

Morgan Engineered Materials Division

Β 

Advanced Materials &Technology Business - (formerly Carbon)

Β 

The Advanced Materials & Technology business has continued to recover across the broad range of its end markets in the third quarter of the year. Of particular note has been the strength of growth in our China business. The cost reduction initiatives started in 2009 and continuing in 2010, combined with our commitment to a low cost strategy, continue to yield benefits in our operating profit levels. We continue to pursue opportunities in the renewable energy sector with growing success in both the wind and solar energy markets.

Β 

Β 

NP Aerospace

Β 

NP Aerospace is expected to deliver 2010 revenues in line with our previously stated expectations of c.Β£120m. The business continues to pursue a number of domestic and international opportunities with existing and new customers. To support this, we have officially launched NP Aerospace in the US, opening an office in Detroit, and we are actively engaged with potential new customers on current and future US programmes.

Β 

Β 

Β Molten Metal Systems

Β 

The strong performance in the Molten Metal Systems business in the first half has continued through the third quarter and we have continued to see increased demand levels in emerging markets.

Β 

Β 

Financial position

Β 

There was no material change in the financial position of the Group during the period. The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end.

Β 

Β 

For further enquiries:

Mark Robertshaw

Morgan Crucible

01753 837000

Kevin Dangerfield

Rollo Head/Clare Hunt

Finsbury

020 7251 3801

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBIBDBIXBBGGL
Date   Source Headline
7th Apr 20143:49 pmRNSDirector/PDMR Shareholding
2nd Apr 20145:03 pmRNSAnnual Financial Report
1st Apr 201410:40 amRNSDirector/PDMR Shareholding
31st Mar 20144:21 pmRNSDirector/PDMR Shareholding
28th Mar 201410:14 amRNSDirector/PDMR Shareholding
25th Mar 201411:59 amRNSDirector/PDMR Shareholding
25th Mar 20149:46 amRNSDirector/PDMR Shareholding
24th Mar 20145:05 pmRNSDirector/PDMR Shareholding
3rd Mar 20144:15 pmRNSDirector/PDMR Shareholding
3rd Mar 201412:27 pmRNSDirector/PDMR Shareholding
28th Feb 201412:57 pmRNSDirector/PDMR Shareholding
21st Feb 20142:18 pmRNSDirector/PDMR Shareholding
18th Feb 20149:21 amRNSHolding(s) in Company
13th Feb 20147:00 amRNSFull Year Results
7th Feb 201410:31 amRNSDirectorate Change
16th Dec 201310:42 amRNSBlocklisting Interim Review
10th Dec 20134:54 pmRNSDirector/PDMR Shareholding
9th Dec 201310:40 amRNSDirector/PDMR Shareholding
29th Nov 201311:00 amRNSTotal Voting Rights
21st Nov 20139:00 amRNSCapital Markets Day
20th Nov 20132:29 pmRNSIssue of Equity
14th Nov 20138:54 amRNSHolding(s) in Company
11th Nov 20137:00 amRNSInterim Management Statement
30th Oct 201310:00 amRNSScrip Dividend Price
28th Oct 20134:11 pmRNSHolding(s) in Company
25th Sep 20133:39 pmRNSHolding(s) in Company
12th Sep 20135:14 pmRNSHolding(s) in Company
12th Sep 20134:52 pmRNSHolding(s) in Company
12th Sep 20134:13 pmRNSHolding(s) in Company
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.